Insight Molecular Diagnostics Inc. Sale of Stock, Consideration Received on Transaction
Insight Molecular Diagnostics Inc. (IMDX) reported Sale of Stock, Consideration Received on Transaction of $37.30 million for the 1-month period ending 2019-02-28, per its 10-Q filed 2019-08-14.
Discontinued › Notes › Equity
us-gaap:SaleOfStockConsiderationReceivedOnTransaction · last filed 2019-08-14
- 2019-02-28: Sale of Stock, Consideration Received on Transaction 1 month $37.30M.
- 2017-02-17: Sale of Stock, Consideration Received on Transaction $2.00M.
- 2016-08-29: Sale of Stock, Consideration Received on Transaction $9.80M; Sale of Stock, Consideration Received on Transaction 0 month $9.80M.
| Period end | Sale of Stock, Consideration Received on Transaction | Sale of Stock, Consideration Received on Transaction 0 month | Sale of Stock, Consideration Received on Transaction 1 month |
|---|---|---|---|
| 2019-02-28 | $37.30M 10-Q · filed 2019-08-14 | ||
| 2017-02-17 | $2.00M 10-Q · filed 2017-11-14 | ||
| 2016-08-29 | $9.80M 10-K · filed 2018-04-02 | $9.80M 10-Q · filed 2018-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |